Zld news, page-32

A good comparison would be gw pharma. They have a cpl products for epilepsy and something else. Only one is soon to be registered and they have a maket cap of several billion.

A fair few companies have products that they are importing or manafacturing themselves, but none have been put through clinical trials and thus arent registered. Thats where the real value is, clinical trials and IP, which is exactly what zelda are doing. They are taking their time and doing it all properly which will prove to be successful in the long term. Unlike some of the other companies who seem to be rushing into anything to do with cannabis. It may work for them in the short term but once companies like zelda bring out their products with clinical evidence to back it up, i reckon they will take over as the medicine of choice for docs when prescribing.

And lets not forget about the access to rhe south American market!